3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
28
Burkitt Lymphoma
20
Leukemia, Myeloid, Acute
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
7
Myeloproliferative Disorders
5
Myelodysplastic Syndromes
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large B-Cell, Diffuse
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Myeloid, Accelerated Phase
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Leukemia, Biphenotypic, Acute
5
Hodgkin Disease
5
Congenital Abnormalities
5
Lymphoma, Large-Cell, Anaplastic
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Blast Crisis
4
Anemia, Refractory, with Excess of Blasts
4
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Lymphoma
3
Hematologic Neoplasms
3
Chromosome 5q Deletion Syndrome
3
Breast Neoplasms
3
Waldenstrom Macroglobulinemia
2
Sezary Syndrome
2
Recurrence
2
Primary Myelofibrosis
2
Interventions
Cisplatin
75
Cetuximab
63
Radiotherapy
38
pembrolizumab
29
Radiotherapy, Intensity-Modulated
28
Carboplatin
25
Fluorouracil
24
Docetaxel
24
Paclitaxel
19
Erlotinib Hydrochloride
13
Nivolumab
12
Radiation
10
Pemetrexed
10
durvalumab
8
Gemcitabine
8
Drug Therapy
8
Bevacizumab
7
zalutumumab
6
Surgical Procedures, Operative
6
Panitumumab
6
Lapatinib
6
Everolimus
6
Albumin-Bound Paclitaxel
6
130-nm albumin-bound paclitaxel
6
epacadostat
5
Standard of Care
5
Oxaliplatin
5
Gefitinib
5
Afatinib
5
Radiosurgery
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Head and Neck Neoplasms
×
merphos
×
Clear all
No trials found.